Haoxiangni Health Food Co.,Ltd. (SHE:002582)
China · Delayed Price · Currency is CNY 11.67
-0.30 (-2.51%)
At close: Feb 13, 2026
Haoxiangni Health Food Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,496 | 1,611 | 1,673 | 1,340 | 1,235 | 2,953 |
Other Revenue | 58.77 | 58.77 | 54.86 | 60.29 | 46.41 | 48.8 |
| 1,555 | 1,670 | 1,728 | 1,400 | 1,281 | 3,001 | |
Revenue Growth (YoY) | -14.32% | -3.39% | 23.40% | 9.32% | -57.32% | -49.65% |
Cost of Revenue | 1,169 | 1,303 | 1,285 | 1,150 | 955.49 | 2,483 |
Gross Profit | 385.62 | 366.68 | 443.66 | 250.72 | 325.63 | 518.27 |
Selling, General & Admin | 395.62 | 461.87 | 495.43 | 433.04 | 370.07 | 675.02 |
Research & Development | 22.5 | 20.64 | 28.57 | 38.65 | 34.19 | 34 |
Other Operating Expenses | 6.66 | 5.06 | 2.95 | 14.16 | 14.88 | 26.9 |
Operating Expenses | 430.17 | 493.42 | 531.09 | 517.61 | 420.65 | 758.44 |
Operating Income | -44.56 | -126.74 | -87.44 | -266.89 | -95.02 | -240.17 |
Interest Expense | -24.03 | -26.68 | -18.5 | -13.58 | -15.82 | -29.18 |
Interest & Investment Income | 49.3 | 92.87 | 49.81 | 55.3 | 75.46 | 3,179 |
Currency Exchange Gain (Loss) | -0.01 | -0.01 | - | - | 0.11 | -16.57 |
Other Non Operating Income (Expenses) | 1.38 | -0.75 | -0.79 | -0.67 | -0.65 | -0.98 |
EBT Excluding Unusual Items | -17.92 | -61.31 | -56.92 | -225.84 | -35.92 | 2,892 |
Gain (Loss) on Sale of Investments | 19.18 | -8.69 | -1.46 | -0.74 | 79.61 | 3.63 |
Gain (Loss) on Sale of Assets | -1.65 | -4.53 | -0.33 | 0.01 | 1.3 | -6.36 |
Asset Writedown | -5.71 | -5.75 | -2.94 | -29.44 | -8.69 | -57.38 |
Other Unusual Items | 4.83 | 4.83 | 10.87 | 21.86 | 30.38 | 80.19 |
Pretax Income | -1.26 | -75.44 | -50.78 | -234.17 | 66.68 | 2,912 |
Income Tax Expense | 17.38 | 0.27 | 5.76 | -31.32 | 11.75 | 763.61 |
Earnings From Continuing Operations | -18.65 | -75.71 | -56.54 | -202.85 | 54.93 | 2,148 |
Minority Interest in Earnings | 2.69 | 3.76 | 4.64 | 13.43 | 6.7 | 6.97 |
Net Income | -15.96 | -71.96 | -51.89 | -189.42 | 61.63 | 2,155 |
Net Income to Common | -15.96 | -71.96 | -51.89 | -189.42 | 61.63 | 2,155 |
Net Income Growth | - | - | - | - | -97.14% | 1018.80% |
Shares Outstanding (Basic) | 480 | 450 | 432 | 441 | 474 | 502 |
Shares Outstanding (Diluted) | 480 | 450 | 432 | 441 | 474 | 502 |
Shares Change (YoY) | 15.97% | 4.00% | -1.83% | -7.09% | -5.62% | -0.90% |
EPS (Basic) | -0.03 | -0.16 | -0.12 | -0.43 | 0.13 | 4.29 |
EPS (Diluted) | -0.03 | -0.16 | -0.12 | -0.43 | 0.13 | 4.29 |
EPS Growth | - | - | - | - | -96.97% | 1028.95% |
Free Cash Flow | 28.67 | -38.19 | 343.67 | -278.78 | -124.7 | 232.9 |
Free Cash Flow Per Share | 0.06 | -0.09 | 0.80 | -0.63 | -0.26 | 0.46 |
Dividend Per Share | 1.000 | 1.400 | 0.600 | 0.100 | 0.100 | 1.000 |
Dividend Growth | - | 133.33% | 500.00% | - | -90.00% | 1062.79% |
Gross Margin | 24.80% | 21.96% | 25.67% | 17.90% | 25.42% | 17.27% |
Operating Margin | -2.87% | -7.59% | -5.06% | -19.06% | -7.42% | -8.00% |
Profit Margin | -1.03% | -4.31% | -3.00% | -13.53% | 4.81% | 71.80% |
Free Cash Flow Margin | 1.84% | -2.29% | 19.89% | -19.91% | -9.73% | 7.76% |
EBITDA | 65.48 | -15.77 | 24.78 | -150.58 | 12.74 | -109.44 |
EBITDA Margin | 4.21% | -0.94% | 1.43% | -10.75% | 1.00% | -3.65% |
D&A For EBITDA | 110.04 | 110.97 | 112.21 | 116.31 | 107.76 | 130.73 |
EBIT | -44.56 | -126.74 | -87.44 | -266.89 | -95.02 | -240.17 |
EBIT Margin | -2.87% | -7.59% | -5.06% | -19.06% | -7.42% | -8.00% |
Effective Tax Rate | - | - | - | - | 17.62% | 26.23% |
Revenue as Reported | 1,555 | 1,670 | 1,728 | 1,400 | 1,281 | 3,001 |
Advertising Expenses | - | 136.62 | 146.85 | 122.89 | 88.13 | 282.39 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.